logo
Why Do Treehoppers Have Such Bizarro Body Shapes?

Why Do Treehoppers Have Such Bizarro Body Shapes?

Forbes08-08-2025
Treehoppers detect electrical fields emitted by their predators and may also distinguish between electrical fields emitted by their predators and friendly insects.
Treehoppers are small, gentle insects that are famous for their astonishing morphological diversity – there's about 3,200 species of treehoppers in over 400 genera and they vary tremendously in shape and include bizarre features such as horns, spines, balls and tridents (Figure 1).
But what is the function of their extraordinary body shapes? Could it be for camouflage, mimicry, or perhaps for physical defense? These are interesting ideas, but such explanations don't make sense for the entire family of treehoppers.
Based on the recent discovery that bumblebees and their flowers communicate using static electricity (ref), the authors of that study followed up by asking whether the distinctive body shapes of treehoppers might help them detect static electricity, too.
'If we can link treehopper shapes to certain aspects of their electrical ecology, like specific predators which approach from certain angles with particular static charges, this would really begin to strongly support our ideas around static electricity as an evolutionary driver,' lead author, ecological physicist Sam England, said. Dr England is currently a postdoctoral fellow at the Museum für Naturkunde–Leibniz Institute for Evolution and Biodiversity Science, but this particular study was part of the requirements for the PhD at the University of Bristol.
Dr England and collaborators investigated this phenomenon by using a picoammeter to measure treehopper static electricity (Figure 2A). They found that these insects retreat from electrical fields.
Dr England and collaborators then found that predatory wasps emit electrical fields (Figure 2B,C,D,E) that are significantly different in both magnitude and polarity from those emitted by friendly stingless bees that often protect treehoppers from their predators.
This difference in electrical charge suggests that treehoppers may use electroreception to distinguish between friends and foes, and thus provides a powerful evolutionary reason for treehoppers to have sensitive electroreception capabilities.
Dr England and collaborators then used computational methods to demonstrate that the extreme body shapes of treehoppers enhance the electric field strength around the treehopper, and this likely increases their sensitivity to static electricity, thereby providing a powerful reason for them to evolve and maintain their weird body shapes.
Are all insects capable of electroreception?
'We don't know for certain how widespread this electrostatic sense is, but given the diversity of animals already shown to have it, plus the breadth of ecological functions they use it for, we feel quite strongly that this sense may be very widespread, especially amongst insects and other small animals,' Dr England replied in email.
If electroreception is so widespread amongst insects, why aren't they all bizarrely shaped?
'The answer is likely manyfold, but one answer is that evolution is a process dictated by chance and tradeoffs,' Dr England explained in email.
For example, although many animals would probably benefit from having the acute vision of an eagle, most lineages haven't evolved the sensory adaptations necessary for such good vision because the random mutations required to start building a highly acute eye haven't occurred in their lineages, or the physiological cost of maintaining such an eye in most species is greater than the survival benefit they would gain from having better vision, making it maladaptive to have such acute vision.
'In the same ways, maybe treehoppers just happened to stumble across the original mutations that allowed them to grow these elaborate pronotums that other insects just didn't get so lucky with,' Dr England observed in email, 'or something about the electric ecology of treehoppers, like the subtle differences we observed between the charges of predators and mutalists of the treehoppers, means they especially benefit from a hyper-sensitive electroreceptive system, that justifies the costly construction of these large electroreceptive structures.'
By demonstrating that the extreme morphology of treehoppers increases the strength of electric field stimuli around these animals, Dr England and collaborators suggest that the enigmatic function of their spectacular pronota is partly as an electroreceptor, and that natural selection for increased electrical sensitivity may have contributed to their diverse evolution.
'We think our study provides a really exciting launch pad for investigating static electricity as a driver of organismal morphology more generally,' Dr England said.
Dr England and collaborators are planning to investigate how different treehopper morphologies could be adaptive for different electrical environments. Further, there's other insects, spiders, animals – and even plants – that also have really extreme shapes, which in many cases are currently without explanation.
'Our study provides the first evidence of the electrostatic sense potentially driving morphological evolution, but we can't prove this just yet.'
Source:
Sam J. England, Ryan A. Palmer, Liam J. O'Reilly, Isaac V. Chenchiah, and Daniel Robert (2025). Electroreception in treehoppers: How extreme morphologies can increase electrical sensitivity, Proceedings of the National Academy of Sciences 122(30):e2505253122 | doi:10.1073/pnas.2505253122
© Copyright by GrrlScientist | hosted by Forbes | LinkTr.ee
Socials: Bluesky | CounterSocial | LinkedIn | Mastodon Science | Spoutible | SubStack | Threads | Tumblr | Twitter
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

This Bright Dot May Be an Entirely New Type of Space Object
This Bright Dot May Be an Entirely New Type of Space Object

Gizmodo

timean hour ago

  • Gizmodo

This Bright Dot May Be an Entirely New Type of Space Object

At first, the dot looked like any other star. Then the astrophysicists switched to polarized light and found themselves looking at an entirely unexpected sight. 'Everything else disappeared, even the bright central black hole, and only this little dot remained,' Elena Shablovinskaia, an astrophysicist at Universidad Diego Portales in Chile and the Max Planck Institute for Radio Astronomy in Germany, told Gizmodo. Shablovinskaia's team believes they've discovered an entirely new kind of space object, which they've dubbed 'Punctum.' Like its name, Latin for 'point' or 'dot,' Punctum is a compact, bright splotch of light in space—but it's only visible at millimeter wavelengths and harbors an unusually organized magnetic field. A paper on Punctum has been accepted for publication in Astronomy & Astrophysics and is currently available on arXiv. The team wanted to show that Punctum is simply an unusual example of a known phenomenon, such as a magnetar or a supernova remnant. NGC 4945, where Punctum lives, is a nearby galaxy known for hosting an active population of baby stars—so it made sense to assume Punctum was one of them. After all, NGC 4945 resides so close to the Milky Way that astrophysicists thought they had a solid grasp of the galaxy. We couldn't have missed something 'hiding in plain sight,' as Shablovinskaia put it…could we? But the more they tried to force Punctum into established astrophysical wisdom, the more it seemed to defy it. For example, Punctum disappeared when the team checked the same region using X-ray or radio telescopes, appearing only in the millimeter spectrum with the Atacama Large Millimeter/submillimeter Array (ALMA). ALMA's ability to capture polarized light also revealed Punctum's weird magnetic field to the scientists, adding to its mystery. Astronomers Calculate Universe's Age With Atacama Desert Telescope 'So we compared its brightness, polarization, and spectrum to every extreme object we could think of—magnetars, pulsars, star-forming regions, and black hole jets,' Shablovinskaia recalled. 'Nothing matched.' But accepting that they'd struck something entirely new only raised more questions. What exactly is it? Where does Punctum—10,000 to 100,000 times brighter than magnetars and 10 to 100 times brighter than most supernovas—get its light? Could it be connected to a black hole or a neutron star? For Shablovinskaia, the best shot at finding the answer might be to investigate Punctum's strange polarization, 'basically a fingerprint of the magnetic environment,' she said. After all, the disturbingly neat alignment of the light waves around Punctum was what alerted the team to the object's weirdness. 'Usually, when light is produced in cosmic environments, it comes out mixed and disordered because the magnetic fields are tangled,' she explained. 'If we can measure [Punctum's magnetic field] at more wavelengths or watch how it changes over time, we can start to figure out what powers Punctum and whether it links to known astrophysical objects.' 'Punctum shows us the universe can still surprise us in places we thought we understood well,' Shablovinskaia said. 'For me, it's a reminder that astronomy is far from finished; we're still just beginning to discover the full variety of cosmic objects out there.' The new research marks another strong example of multi-messenger astronomy, in which astronomers use different kinds of signals to investigate a single source. Recently, astronomers found an ultramassive black hole using gravitational lensing. In this case, the scientists studied a specific behavior of light—polarization—alongside more conventional methods to double-check their results.

ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System

Yahoo

time2 hours ago

  • Yahoo

ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) The investigational device exemption (IDE) allows initiation of a global pivotal study designed to assess the safety and efficacy of the ARCIM System®, an implantable neurostimulation technology developed to address blood pressure instability after spinal cord injury (SCI). Managing blood pressure instability is a major unmet need after SCI, with a significant impact on cardiovascular health and quality of life. Approximately 20 leading neurorehabilitation and neurosurgical research centers across the US, Canada and Europe are expected to participate. EINDHOVEN, The Netherlands, Aug. 18, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury and other movement disabilities, today announces that the US Food and Drug Administration (FDA) has approved an investigational device exemption for the ARC-IM System. With this approval, the Company can initiate the Empower BP pivotal study to assess the safety and efficacy of its implantable spinal stimulation system to address blood pressure instability after SCI. Empower BP is the Company's second global pivotal study, and the first to evaluate the implantable ARC-IM System. The randomized, double-blinded, sham-controlled study is expected to involve approximately 20 leading neurorehabilitation and neurosurgical research centers across the US, Canada and Europe, with first patient enrollment anticipated before the end of the year. The study will target participants with injuries at spinal cord levels C2-T6, injury severities of AIS A-D, and blood pressure instability characterized by chronic orthostatic hypotension (OH) and episodes of autonomic dysreflexia (AD). 'This is an important milestone for ONWARD and the SCI community,' said Dave Marver, CEO of ONWARD. 'Our ARC-IM System is designed to address several unmet needs, including blood pressure instability which is a major recovery target after spinal cord injury. With this IDE approval, we continue to advance our innovation pipeline and inspire realistic hope in restoring autonomic functions and independence after SCI and other movement disabilities.' Over 50% of people with SCI experience blood pressure instability, affecting nearly 350,000 people in the US and Europe.1 Blood pressure instability and persistent low blood pressure can threaten neurological recovery and negatively impact cardiovascular health and quality of life. The most frequent symptoms include dizziness, lightheadedness, blurred vision and fatigue.2 'Blood pressure instability, especially chronic low blood pressure, is one of the most hidden and unrecognized functional complications of spinal cord injury,' explains Dr. James Guest, neurosurgeon and Professor of Neurological Surgery at the University of Miami. 'It leaves people feeling unwell and can significantly impact their overall quality of life. Blood pressure instability also increases the risk of cardiovascular disease, making addressing this unmet need critical for improving the long-term outcomes of SCI.' The ONWARD ARC-IM System is an implanted neuromodulation platform designed to deliver targeted and personalized spinal cord stimulation. It is the first neuroprosthetic system designed to manage blood pressure instability in people with SCI. It comprises the implanted ONWARD Neurostimulator (IPG) and the ARC-IM Thoracic Lead. The ARC-IM Thoracic Lead is optimized for surgical placement in a specific region of the thoracic spinal cord, called the 'Hemodynamic Hotspot'. The location was first discovered by the Company's research partners at the Swiss Federal Institute of Technology Lausanne (EPFL), Centre Hospitalier Universitaire Vaudois (CHUV), and the University of Calgary in a study published in Nature in January 2021.3 In December 2022, the Company announced positive top-line interim clinical results from its feasibility studies showing improved blood pressure regulation and improved hemodynamic stability after SCI. In addition to immediate and sustained improved blood pressure levels, participants taking anti-hypotension drugs prior to the study significantly reduced or discontinued their medication. Participants also reported improved general well-being and a reduction in orthostatic hypotension, including reduced dizziness and increased energy. Detailed interim results from these studies are expected to be published later this year. Managing blood pressure instability is among the major unmet needs for which the FDA has awarded the Company one of its 10 Breakthrough Device Designations. This award is reserved for novel, cutting-edge therapies addressing unmet needs and provides potential regulatory and reimbursement benefits. To stay informed about ONWARD's research studies, technologies, and the availability of therapies in your area, please complete this webform. About ONWARD Medical ONWARD Medical is the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries, and other movement disabilities. Building on over a decade of scientific discovery, preclinical research, and clinical studies conducted at leading hospitals, rehabilitation clinics, and neuroscience laboratories, the Company developed ARC Therapy. It has subsequently been awarded 10 Breakthrough Device designations from the FDA. The Company's ARC-EX® System is cleared for commercial sale in the US. The Company is also developing an investigational implantable system called ARC-IM, which can be paired with a brain-computer interface (BCI) to restore thought-driven movement. Headquartered in the Netherlands, the Company has a Science and Engineering Center in Switzerland and a US office in Boston, Massachusetts. The Company is listed on Euronext Paris, Brussels, and Amsterdam (ticker: ONWD) and its US ADRs can be traded on OTCQX (ticker: ONWRY). For more information, please visit For Media Inquiries: Sébastien Cros, VP Communications media@ For Investor Inquiries: investors@ Notes and references: 1. Katzelnick CG et al. Blood Pressure Instability in Persons With SCI: Evidence From a 30-Day Home Monitoring Observation. Am J Hypertens. 2019 Sep 24;32(10):938-944 2. Carlozzi, N. E. et al. Impact of blood pressure dysregulation on health-related quality of life in persons with spinal cord injury: development of a conceptual model. Arch. Phys. Med. Rehabil. 94, 1721–1730 (2013) 3. Squair, J.W. et al. Neuroprosthetic baroreflex controls haemodynamics after spinal cord injury. Nature 590, 308–314 (2021) Forward-Looking Statements Certain statements, beliefs, and opinions in this press release are forward-looking, which reflect the Company's or, as appropriate, the Company directors' current expectations and projections about future events. By their nature, forward-looking statements involve several risks, uncertainties, and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, delays in regulatory approvals, changes in demand, competition, and technology, can cause actual events, performance, or results to differ significantly from any anticipated development. Forward-looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, the Company expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions, or circumstances on which these forward-looking statements are based. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person's officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Reclaiming Innovation in Patient-Centered Care
Reclaiming Innovation in Patient-Centered Care

Medscape

time4 hours ago

  • Medscape

Reclaiming Innovation in Patient-Centered Care

Medscape 2050: The Future of Medicine Summary: In this wide-ranging, deeply thoughtful commentary, Professor Christina Pagel, professor of operational research at University College London, underscores why data and AI, while transformative, are not silver bullets for modern healthcare challenges. Drawing from decades of experience working directly with clinicians, Pagel illustrates how collaborative, multidisciplinary environments drive more meaningful innovation than technology alone. She cautions against overreliance on AI, noting its limitations in upstream determinants of health and long-term outcomes. Instead, Pagel champions a model of medicine that prioritizes well-being, long-term survival, and access to care — especially for populations often ignored by traditional metrics and research, such as women with chronic menstrual pain. From clean water access to systemic underinvestment in "unsexy" conditions, Pagel's insights invite a critical rethinking of how medicine should evolve: not by replacing human judgment with algorithms, but by strengthening the diverse human networks that define healthcare's most effective interventions. Key Takeaways:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store